SUMMARY
Rationale Gastrointestinal fistulas (GIF) represent a severe and potentially lethal complication of the hospital surgical activity. However, evidences are lacking about prognosis and outcomes of GIF in Latin America (LATAM) hospitals.
Objective To describe the prognosis and outcomes GIF in LATAM hospitals.
Study design Prospective, longitudinal, cohort-type study. The cohort fostered three cross-sectional examinations: First examination: On admission of the patient in the study; Second examination: Thirty days later; and Third (and last) examination: Sixty days after patient’s admission.
Study serie One hundred seventy-seven patients (Males: 58.2 %; Average age: 51.0 ± 16.7 years; Ages ≥ 60 years: 36.2 %) diagnosed with, and assisted for, GIF (ECF: Enterocutaneous: 64.9 % vs. EAF: Enteroathmospheric: 35.1 %) in 76 LATAM hospitals (13 countries) and Europe (4).
Methods Condition (Alive vs. Deceased) and hospital status (Hospitalized vs. Discharged) of the patient, and the GFI patency (Closed vs. Non closed) were recorded in each of the cohort’s examination. Indicators of GFI prognosis thus constructed were correlated demographical, sanitary, surgical and nutritional characteristics of the patients
Results On conclusion of the study indicators of GIF prognosis behaved as follows: Mortality:14.7 %; Prolonged hospitalization: 47.4 %; Spontaneous closure of GIF: 36.2 %. Type of GIF influenced upon patient’s survival: ECF: 87.0 % vs. EAF: 82.3 % (Δ = +4.7 %; χ2 = 6.787; p < 0.05). In each examination of the cohort, the number of surviving subjects was always greater among those with ECF: After 30 days: ECF: 92.1 % vs. EAF: 83.9 % (Δ = +8.2 %); After 60 days: ECF: 98.1 % vs. EAF: 90.4 % (Δ = +7.7 %; χ2 = 13.764; p < 0.05). On the other hand, hospital stay was prolonged in the subjects of elective surgery (Elective surgery: 61.4 % vs. Emergency surgery: 38.3 % (Δ = +23.1 %; χ2 = 9.064; p < 0.05) and those with a reduced calf circumference (χ2 = 12.655; p < 0.05). Location of the fistula also influenced upon prolongation of hospital stay (χ2 = 7.817; p < 0.05).
Conclusions Type of GIF influences upon survival of the patient. On the hand, hospital stay was dependent upon type of surgery previously performed, location of the fistula, and calf circumference value on admission in the study serie.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
In lieu of the observational nature of the present study, no attempt was made to promote lest register it as a clinical trial.
Funding Statement
No external funding was used for completion of the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol followed by local surveyors during the "Fistula Day" was drafted according with "Good Clinical Practices". Identity and rights of the surveyed patients were also protected. The patients (and by extension their caretakers) were informed about the purposes of the research, and the non-invasive nature of the procedures. The collected data were adequately preserved in order to ensure anonymity and confidentiality. Aggregated data were used in the interpretation of the results and the realization of statistical inferences. Informed consent was obtained from the patient before inclusion in the cohort. Local conduction of the activities foreseen in the "Fistula Day" was authorized and supervised by the Committees of Ethics of the participating hospitals after presentation, review and approval of the research protocols. The researchers entrusted with the conduction of the "Fistula Day Project" presented the protocol "Current status of the postoperative fistula of digestive tract; multicentric, multinational study. DAY OF THE FISTULA" before the Ethics Committee of the San Javier Hospital (city of Guadalajara, State of Jalisco, Mexico) for review and approval. A ruling was emitted on April 11th, 2018 by Dr. Eduardo Razon Gutierrez, acting Director of the Ethics Committee, with the approval of the research protocol and the authorization for the conduction of the "Fistula Day" Project.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Interested researchers should address the authors for policies regarding access to the study data.
